Investigating the role of IL-7R in autoimmune diseases affecting the central nervous system
Role of IL-7R in CNS autoimmunity
This study is looking at how a specific part of the immune system, called the IL-7 receptor, affects autoimmune diseases like multiple sclerosis, with the goal of finding new ways to help improve treatments for people living with MS.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10984959 on NIH RePORTER |
What this research studies
This research focuses on understanding how the IL-7 receptor (IL-7R) influences autoimmune conditions like multiple sclerosis (MS) by examining its role in the immune system, particularly in T and B cell development. The study utilizes animal models to explore the mechanisms by which IL-7R signaling may contribute to the severity of CNS autoimmunity. By analyzing the effects of IL-7R on dendritic cells and regulatory T cells, the research aims to uncover potential therapeutic targets for improving treatment outcomes in patients with MS.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with multiple sclerosis or those at risk due to genetic factors associated with IL-7R.
Not a fit: Patients with autoimmune conditions unrelated to the central nervous system or those without genetic predispositions to IL-7R-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that better manage or prevent the progression of multiple sclerosis and other CNS autoimmune diseases.
How similar studies have performed: Previous research has indicated that targeting IL-7R may have therapeutic potential in autoimmune diseases, suggesting that this approach could yield meaningful insights.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Rostami, A.m. — Thomas Jefferson University
- Study coordinator: Rostami, A.m.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.